Paragon Care EBIT per Share
EBIT per Share of Paragon Care (PGC.AX) as of Nov 4, 2026.
Get this data via API
Financial Data API
EBIT per Share
0.00AUD
YoY
-92.75%
Last updated:
EBIT per Share of Paragon Care is 2026 0.00 AUD. EBIT per Share of Paragon Care was 2025 0.05 AUD. It decreases by -92.75% lower compared to the previous year.
The Paragon Care EBIT per Share history
3 Years
10 Years
25 Years
Max
EBIT per Share
Date
EBIT per Share
Jan 1, 2022
0.03 AUD
Jan 1, 2023
0.04 AUD
Jan 1, 2024
0.03 AUD
Jan 1, 2025
0.05 AUD
Jan 1, 2026
0.00 AUD
Jan 1, 2027 (e)
0.04 AUD
Jan 1, 2028 (e)
0.05 AUD
Jan 1, 2029 (e)
0.05 AUD
| YEAR | EBIT per Share | YoY |
|---|---|---|
| est | 0.05AUD | +1.16% |
| est | 0.05AUD | +19.17% |
| est | 0.04AUD | +997.00% |
| 0.00AUD | -92.75% | |
| 0.05AUD | +72.33% | |
| 0.03AUD | -18.98% | |
| 0.04AUD | +20.96% | |
| 0.03AUD | +49.45% | |
| 0.02AUD | +242.38% | |
| 0.01AUD | -78.36% | |
| 0.03AUD | -48.24% | |
| 0.06AUD | +132.67% | |
| 0.02AUD | +23.60% | |
| 0.02AUD | +274.17% | |
| 0.01AUD | +124.41% | |
| 0.00AUD | +22.73% | |
| 0.00AUD | -938.45% | |
| -0.00AUD | -74.09% | |
| -0.00AUD | -39.79% | |
| -0.00AUD | +154.24% | |
| -0.00AUD | -81.03% | |
| -0.00AUD | +36.12% | |
| -0.00AUD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Paragon Care Stock analysis
What does Paragon Care do? Paragon Care Ltd supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets across Australia, New Zealand, and Asia. The company operates through four segments: Capital and Consumables, which includes medical, surgical, and veterinary services; Devices, covering ophthalmology, optometry, orthopedics, pain management, surgical procedure packs, and infection prevention; Diagnostics, distributing blood bank diagnostics, clinical pathology diagnostics, and scientific laboratory equipment; and Service and Technology, offering biomedical device services, high-end capital equipment support, and technology management partnerships with various brands.
The Capital and Consumables segment serves healthcare providers and aged care facilities requiring durable equipment and consumables, while the Devices segment targets clinics and hospitals needing specialized medical devices. The Diagnostics segment supplies laboratories and healthcare institutions with diagnostic tools and equipment, and the Service and Technology segment partners with brands to provide comprehensive service and technology solutions for biomedical and capital equipment.
Healthcare providers, aged care facilities, clinics, hospitals, and laboratories are key customers purchasing Paragon Care's products and services. The company's segments align with specific market needs, ensuring tailored offerings for each sector, from surgical supplies to advanced diagnostic equipment and technical support services. Paragon Care is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Paragon Care stock
On Eulerpool you can find the complete historical development of EBIT per Share Paragon Care since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Paragon Care
All Key Metrics — Paragon Care
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth